BIOGEN INC (BIIB) Stock Analyst Ratings
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to BIIB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 243.18. This target is 70.36% above the current price.
BIIB was analyzed by 42 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about BIIB.
In the previous month the buy percentage consensus was at a similar level.
BIIB was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-02 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-12-20 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-12-10 | B of A Securities | Reiterate | Neutral |
| 2024-12-09 | Jefferies | Downgrade | Buy -> Hold |
| 2024-11-21 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-11-18 | Needham | Downgrade | Buy -> Hold |
| 2024-11-15 | Wolfe Research | Initiate | Peer Perform |
| 2024-11-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-14 | Citigroup | Initiate | Neutral |
| 2024-11-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-31 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-31 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | Needham | Reiterate | Buy -> Buy |
| 2024-10-17 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-10 | Raymond James | Reiterate | Market Perform |
| 2024-10-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-03 | UBS | Maintains | Neutral -> Neutral |
| 2024-09-24 | Needham | Reiterate | Buy -> Buy |
| 2024-09-23 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-19 | Needham | Reiterate | Buy -> Buy |
| 2024-08-06 | Mizuho | Maintains | Outperform -> Outperform |